nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfinpyrazone—CYP3A4—bone cancer	0.275	1	CbGaD
Sulfinpyrazone—ABCC6—Cisplatin—bone cancer	0.118	0.172	CbGbCtD
Sulfinpyrazone—ABCC5—Cisplatin—bone cancer	0.0902	0.132	CbGbCtD
Sulfinpyrazone—ABCC6—Doxorubicin—bone cancer	0.0791	0.115	CbGbCtD
Sulfinpyrazone—ABCC3—Cisplatin—bone cancer	0.0567	0.0827	CbGbCtD
Sulfinpyrazone—ABCC1—Epirubicin—bone cancer	0.0439	0.064	CbGbCtD
Sulfinpyrazone—ABCC3—Doxorubicin—bone cancer	0.038	0.0554	CbGbCtD
Sulfinpyrazone—ABCC3—Methotrexate—bone cancer	0.0368	0.0537	CbGbCtD
Sulfinpyrazone—ABCC2—Carboplatin—bone cancer	0.0302	0.044	CbGbCtD
Sulfinpyrazone—ABCC4—Methotrexate—bone cancer	0.0281	0.041	CbGbCtD
Sulfinpyrazone—ABCC2—Cisplatin—bone cancer	0.0258	0.0376	CbGbCtD
Sulfinpyrazone—ABCC1—Doxorubicin—bone cancer	0.0233	0.034	CbGbCtD
Sulfinpyrazone—ABCC1—Methotrexate—bone cancer	0.0226	0.033	CbGbCtD
Sulfinpyrazone—ABCC2—Doxorubicin—bone cancer	0.0173	0.0252	CbGbCtD
Sulfinpyrazone—ABCC2—Methotrexate—bone cancer	0.0167	0.0244	CbGbCtD
Sulfinpyrazone—CYP2B6—Cisplatin—bone cancer	0.0164	0.0239	CbGbCtD
Sulfinpyrazone—CYP2B6—Doxorubicin—bone cancer	0.011	0.016	CbGbCtD
Sulfinpyrazone—CYP2C9—Cisplatin—bone cancer	0.00866	0.0126	CbGbCtD
Sulfinpyrazone—ABCB1—Cisplatin—bone cancer	0.0084	0.0123	CbGbCtD
Sulfinpyrazone—ABCB1—Doxorubicin—bone cancer	0.00563	0.00821	CbGbCtD
Sulfinpyrazone—ABCB1—Methotrexate—bone cancer	0.00545	0.00796	CbGbCtD
Sulfinpyrazone—CYP3A4—Doxorubicin—bone cancer	0.00337	0.00492	CbGbCtD
Sulfinpyrazone—ABCC3—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00156	0.0404	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00146	0.0379	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00138	0.0356	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00124	0.032	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00116	0.03	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000855	0.0221	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000841	0.0217	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Fluoropyrimidine Activity—DHFR—bone cancer	0.000805	0.0208	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000804	0.0208	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Irinotecan Pathway—CYP3A4—bone cancer	0.000792	0.0205	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000786	0.0203	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Irinotecan Pathway—CYP3A4—bone cancer	0.000783	0.0202	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000678	0.0175	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000666	0.0172	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000666	0.0172	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.000661	0.0171	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000636	0.0165	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNA11—bone cancer	0.000624	0.0161	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Fluoropyrimidine Activity—DHFR—bone cancer	0.000594	0.0154	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000583	0.0151	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Ectoderm Differentiation—BCOR—bone cancer	0.000577	0.0149	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Fluoropyrimidine Activity—DHFR—bone cancer	0.000558	0.0144	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000546	0.0141	CbGpPWpGaD
Sulfinpyrazone—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000545	0.0141	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000542	0.014	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000518	0.0134	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000516	0.0133	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000491	0.0127	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000425	0.011	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000409	0.0106	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000389	0.0101	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000379	0.00981	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000357	0.00924	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000341	0.00882	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000338	0.00875	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000336	0.00869	CbGpPWpGaD
Sulfinpyrazone—Phenylbutazone—CYP3A4—bone cancer	0.000335	0.348	CrCbGaD
Sulfinpyrazone—Phenylbutazone—PTGS2—bone cancer	0.000328	0.341	CrCbGaD
Sulfinpyrazone—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000321	0.00831	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000319	0.00824	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000313	0.0081	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000309	0.00799	CbGpPWpGaD
Sulfinpyrazone—ABCC6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000304	0.00786	CbGpPWpGaD
Sulfinpyrazone—Clotrimazole—CYP3A4—bone cancer	0.000301	0.312	CrCbGaD
Sulfinpyrazone—SLC22A12—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000294	0.00762	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000293	0.00757	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000286	0.00741	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet degranulation—SPARC—bone cancer	0.000281	0.00726	CbGpPWpGaD
Sulfinpyrazone—ABCC1—S1P1 pathway—PTGS2—bone cancer	0.000272	0.00702	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000268	0.00692	CbGpPWpGaD
Sulfinpyrazone—ABCC6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000262	0.00679	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000261	0.00676	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000261	0.00674	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000251	0.0065	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000248	0.00642	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000233	0.00603	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000214	0.00554	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000193	0.00499	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000192	0.00497	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000183	0.00473	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Fluoropyrimidine Activity—TP53—bone cancer	0.00018	0.00465	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00018	0.00464	CbGpPWpGaD
Sulfinpyrazone—ABCC5—NRF2 pathway—GSTP1—bone cancer	0.000178	0.00459	CbGpPWpGaD
Sulfinpyrazone—ABCC5—NRF2 pathway—TGFBR2—bone cancer	0.000178	0.00459	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000171	0.00442	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Carbohydrate metabolism—ENO2—bone cancer	0.000167	0.00432	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000158	0.00408	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000155	0.00402	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000154	0.00398	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00014	0.00361	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000133	0.00345	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Fluoropyrimidine Activity—TP53—bone cancer	0.000133	0.00343	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000132	0.0034	CbGpPWpGaD
Sulfinpyrazone—ABCC3—NRF2 pathway—GSTP1—bone cancer	0.000131	0.00339	CbGpPWpGaD
Sulfinpyrazone—ABCC3—NRF2 pathway—TGFBR2—bone cancer	0.000131	0.00339	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000128	0.0033	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000125	0.00324	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Fluoropyrimidine Activity—TP53—bone cancer	0.000125	0.00323	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000125	0.00322	CbGpPWpGaD
Sulfinpyrazone—ABCC4—NRF2 pathway—GSTP1—bone cancer	0.000123	0.00318	CbGpPWpGaD
Sulfinpyrazone—ABCC4—NRF2 pathway—TGFBR2—bone cancer	0.000123	0.00318	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000121	0.00312	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000114	0.00295	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—NDUFA12—bone cancer	0.000109	0.00282	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000109	0.00281	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000108	0.0028	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000107	0.00277	CbGpPWpGaD
Sulfinpyrazone—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000104	0.00268	CbGpPWpGaD
Sulfinpyrazone—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000104	0.00268	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000103	0.00267	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000103	0.00266	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.68e-05	0.0025	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—NT5C3A—bone cancer	9.04e-05	0.00234	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.89e-05	0.0023	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	8.8e-05	0.00228	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.35e-05	0.00216	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.16e-05	0.00211	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.07e-05	0.00209	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—NDUFA12—bone cancer	8.05e-05	0.00208	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	8.04e-05	0.00208	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	7.98e-05	0.00206	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.04e-05	0.00182	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.96e-05	0.0018	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	6.84e-05	0.00177	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Biological oxidations—CYP3A4—bone cancer	6.79e-05	0.00175	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	6.69e-05	0.00173	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—NT5C3A—bone cancer	6.67e-05	0.00172	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	6.53e-05	0.00169	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—SPARC—bone cancer	6.42e-05	0.00166	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—NDUFA12—bone cancer	6.31e-05	0.00163	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—GNA11—bone cancer	5.87e-05	0.00152	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Biological oxidations—GSTP1—bone cancer	5.8e-05	0.0015	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Biological oxidations—CYP3A4—bone cancer	5.74e-05	0.00149	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	5.72e-05	0.00148	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	5.67e-05	0.00147	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	5.57e-05	0.00144	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	5.55e-05	0.00144	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—IL3—bone cancer	5.32e-05	0.00138	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—NT5C3A—bone cancer	5.22e-05	0.00135	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	5.05e-05	0.00131	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Biological oxidations—GSTP1—bone cancer	4.91e-05	0.00127	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	4.85e-05	0.00125	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—ENO2—bone cancer	4.73e-05	0.00122	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Biological oxidations—CYP3A4—bone cancer	4.68e-05	0.00121	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	4.61e-05	0.00119	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	4.6e-05	0.00119	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	4.54e-05	0.00117	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—DHFR—bone cancer	4.39e-05	0.00114	CbGpPWpGaD
Sulfinpyrazone—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	4.3e-05	0.00111	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.07e-05	0.00105	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—NDUFA12—bone cancer	4.07e-05	0.00105	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Biological oxidations—GSTP1—bone cancer	4e-05	0.00103	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—ENO2—bone cancer	3.96e-05	0.00102	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	3.94e-05	0.00102	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	3.85e-05	0.000995	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.84e-05	0.000992	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—DHFR—bone cancer	3.68e-05	0.000951	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—PLAU—bone cancer	3.49e-05	0.000903	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—NDUFA12—bone cancer	3.44e-05	0.000891	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—GNA11—bone cancer	3.44e-05	0.000888	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—NT5C3A—bone cancer	3.37e-05	0.000872	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.31e-05	0.000857	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—TGFBR2—bone cancer	3.18e-05	0.000823	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—CYP3A4—bone cancer	3.11e-05	0.000805	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NDUFA12—bone cancer	3e-05	0.000776	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—ENO2—bone cancer	2.92e-05	0.000755	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.85e-05	0.000738	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—NT5C3A—bone cancer	2.85e-05	0.000738	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NDUFA12—bone cancer	2.8e-05	0.000725	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—ENO2—bone cancer	2.73e-05	0.000707	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—DHFR—bone cancer	2.71e-05	0.000701	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—GSTP1—bone cancer	2.66e-05	0.000689	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.64e-05	0.000682	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.6e-05	0.000673	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—DHFR—bone cancer	2.54e-05	0.000656	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—GNA11—bone cancer	2.53e-05	0.000655	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NT5C3A—bone cancer	2.49e-05	0.000643	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NT5C3A—bone cancer	2.32e-05	0.000601	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—CYP3A4—bone cancer	2.3e-05	0.000594	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—ENO2—bone cancer	2.29e-05	0.000592	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.28e-05	0.000591	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—KIT—bone cancer	2.17e-05	0.000561	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—DHFR—bone cancer	2.12e-05	0.000549	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.12e-05	0.000547	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—BRAF—bone cancer	2.04e-05	0.000528	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.04e-05	0.000527	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—GNA11—bone cancer	1.98e-05	0.000513	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—GSTP1—bone cancer	1.96e-05	0.000508	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NDUFA12—bone cancer	1.85e-05	0.000478	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.84e-05	0.000476	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—TGFBR2—bone cancer	1.84e-05	0.000475	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—CYP3A4—bone cancer	1.8e-05	0.000465	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.79e-05	0.000463	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—MDM2—bone cancer	1.71e-05	0.000442	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—PTGS2—bone cancer	1.65e-05	0.000426	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—GSTP1—bone cancer	1.54e-05	0.000398	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NT5C3A—bone cancer	1.53e-05	0.000396	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ENO2—bone cancer	1.48e-05	0.000382	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.45e-05	0.000374	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—TP53—bone cancer	1.4e-05	0.000363	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PTGS2—bone cancer	1.38e-05	0.000357	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—DHFR—bone cancer	1.37e-05	0.000354	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GNA11—bone cancer	1.28e-05	0.000331	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—KIT—bone cancer	1.25e-05	0.000324	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ENO2—bone cancer	1.25e-05	0.000323	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.21e-05	0.000314	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—BRAF—bone cancer	1.18e-05	0.000305	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—EGFR—bone cancer	1.17e-05	0.000302	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CYP3A4—bone cancer	1.16e-05	0.0003	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—DHFR—bone cancer	1.16e-05	0.0003	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ENO2—bone cancer	1.09e-05	0.000282	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GNA11—bone cancer	1.08e-05	0.00028	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PTGS2—bone cancer	1.02e-05	0.000263	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ENO2—bone cancer	1.02e-05	0.000263	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—DHFR—bone cancer	1.01e-05	0.000261	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GSTP1—bone cancer	9.92e-06	0.000257	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MDM2—bone cancer	9.87e-06	0.000255	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYP3A4—bone cancer	9.82e-06	0.000254	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.77e-06	0.000253	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PTGS2—bone cancer	9.52e-06	0.000246	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GNA11—bone cancer	9.44e-06	0.000244	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—DHFR—bone cancer	9.44e-06	0.000244	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GNA11—bone cancer	8.82e-06	0.000228	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP3A4—bone cancer	8.56e-06	0.000221	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GSTP1—bone cancer	8.4e-06	0.000217	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP3A4—bone cancer	8e-06	0.000207	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PTGS2—bone cancer	7.97e-06	0.000206	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.95e-06	0.000206	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GSTP1—bone cancer	7.32e-06	0.000189	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSTP1—bone cancer	6.84e-06	0.000177	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—EGFR—bone cancer	6.75e-06	0.000175	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ENO2—bone cancer	6.71e-06	0.000173	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—DHFR—bone cancer	6.22e-06	0.000161	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GNA11—bone cancer	5.82e-06	0.00015	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PTGS2—bone cancer	5.14e-06	0.000133	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTP1—bone cancer	4.51e-06	0.000117	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PTGS2—bone cancer	4.35e-06	0.000113	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PTGS2—bone cancer	3.79e-06	9.81e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PTGS2—bone cancer	3.54e-06	9.16e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PTGS2—bone cancer	2.34e-06	6.04e-05	CbGpPWpGaD
